Skip to content

Clinical trials

Sepsis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sepsis Country / region: China Clear all

266 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20083
20095
20107
201111
20125
20137
201414
20155
201612
201714
201814
201918
202011
202126
202227
202316
202424
202519
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status106
Completed80
Recruiting40
Not yet recruiting21
Enrolling by invitation7
Active, not recruiting5
Terminated3
Withdrawn3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital19
Southeast University, China15
Zhujiang Hospital10
Peking Union Medical College Hospital9
Children's Hospital of Fudan University8
Shanghai Zhongshan Hospital7
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology7
Sun Yat-sen University6
Xiangya Hospital of Central South University6
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis266
Shock, Septic34
Acute Kidney Injury15
Critical Illness12
Respiratory Distress Syndrome11
Infections9
Multiple Organ Failure9
Shock7
Disease6
Inflammation6

Trials

Showing 1 to 25 of 266. Each trial links to its page on Pharma Observatory.

166 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.